Takeda spinout HilleVax goes public, a test of the choppy waters for biotechs on Wall Street
Takeda spinout HilleVax goes public, a test of the choppy [...]
Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact
Jazz, Werewolf to howl at the moon together in $1.26B [...]
Gilead unveils pediatric drug development center in Ireland with 33 new jobs
Gilead unveils pediatric drug development center in Ireland with 33 [...]
Athira board spares no punches to fend off proxy fight from ally of ousted CEO
Athira board spares no punches to fend off proxy fight [...]
Path cleared for Iovance’s lead melanoma drug after FDA assay feedback
Path cleared for Iovance’s lead melanoma drug after FDA assay [...]
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification from Keytruda
Merck looks to cardiovascular pipeline for $10B+ peak sales—and diversification [...]
Big Pharma partnerships, record $22.7B investment raise profile of regenerative medicine in 2021
Big Pharma partnerships, record $22.7B investment raise profile of regenerative [...]
String of NIH departures continues as Ned Sharpless, head of the National Cancer Institute, steps down
String of NIH departures continues as Ned Sharpless, head of [...]
CRISPR patent dispute not over yet as Emmanuelle Charpentier, universities appeal
CRISPR patent dispute not over yet as Emmanuelle Charpentier, universities [...]
ACC: Ionis-AstraZeneca antisense drug reduces troublesome cholesterol in phase 2b
ACC: Ionis-AstraZeneca antisense drug reduces troublesome cholesterol in phase 2b [...]